Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.0B | 8.9B | 9.7B | 8.8B |
| Cost of revenue | 8.0B | 7.5B | 8.7B | 7.7B |
| Gross profit | 2.0B | 1.4B | 1.1B | 1.1B |
| Operating expense | ||||
| Research & development | 290M | 310M | 362M | 326M |
| Selling general and admin | 906M | 752M | 911M | 884M |
| Other operating expenses | 278M | 16M | 42M | — |
| Operating income | 539M | 336M | -190M | -40M |
| Non operating interest income | ||||
| Income | 65M | 63M | 68M | 54M |
| Expense | 65M | 72M | 65M | 106M |
| Other income expense | — | — | — | — |
| Pretax income | 605M | 462M | -69M | -108M |
| Tax provision | 103M | 211M | 184M | -6M |
| Net income | 501M | 252M | -254M | -102M |
| Basic EPS | — | 0.2 | -0.3 | -0.2 |
| Diluted EPS | — | 0.2 | -0.3 | -0.2 |
| Basic average shares | — | 864.3M | 862.8M | 862.8M |
| Diluted average shares | — | 864.3M | 862.8M | 862.8M |
| EBITDA | 1.3B | 904M | 429M | 358M |
| Net income from continuing op. | 501M | 252M | -254M | -102M |
| Minority interests | -68M | -53M | -39M | -40M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |